arrow
R

Rifaat Safadi

Nanjing University
H指数:50
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of belapectin for the prevention of esophageal varices in patients with MASH cirrhosis: The randomized, placebo-controlled NAVIGATE trial

Belapectin预防MASH肝硬化患者食管静脉曲张的疗效与安全性:随机、安慰剂对照的NAVIGATE试验

2026-05-011
PRE
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

25个国家和地区丁型肝炎病毒流行率的调整估计

2024-02-0125
OAAI
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
2023-10-01101
PRE
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

在低HBV和高HBV/HDV流行国家中所有乙型肝炎携带者的丁型肝炎双反射检测

2023-08-0127
OAAI
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
2023-06-2219
OA
Combined hepatocellular-cholangiocarcinoma derives from liver progenitor cells and depends on senescence and IL-6 trans-signaling
2022-12-0130
OAAI
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

丙型肝炎病毒患病率的全球变化以及护理2015年和2020的级联: 一项建模研究

2022-05-01368
OAAI